- Details
- Description
Packaging Size:
60 capsules
Strength:
100 mg
Composition:
Acalabrutinib INN
Treatment:
Anti-Cancer / Oncology
Form:
Capsule
Brand:
ACATINIB
Quantity Unit:
Capsules
Manufacturer:
Ziska Pharmaceuticals Limited
ACATINIB (Acalabrutinib INN) is an oral targeted anti-cancer medicine containing acalabrutinib, a selective Bruton’s tyrosine kinase (BTK) inhibitor that blocks signaling involved in the growth and survival of abnormal B cells. It is primarily used for certain B-cell blood cancers, including chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), and in certain cases of mantle cell lymphoma. ACATINIB is supplied as 100 mg capsules, with a 60-capsule pack.
